Literature DB >> 14725826

Pregnancy, sleep disordered breathing and treatment with nasal continuous positive airway pressure.

Christian Guilleminault1, Martina Kreutzer, Judy L Chang.   

Abstract

OBJECTIVE: To investigate the tolerance, compliance and problems associated with usage of nasal continuous positive airway pressure (CPAP) by pregnant women with sleep disordered breathing (SDB). PATIENTS AND
METHOD: Twelve pregnant women diagnosed with SDB received polysomnography (PSG) at entry, CPAP titration, repeat PSG at 6 months gestation (GA) and home monitoring of cardio-respiratory variables at 8 months GA. Compliance was verified by the pressure at the mask. Results from the Epworth sleepiness scale, fatigue scale and visual analogue scales (VAS) for sleepiness, fatigue, and snoring were compared over time.
RESULTS: All of the subjects had full term pregnancies and healthy infants. Nightly compliance was at least 4 h initially and 6.5 h at 6 months GA. Nasal CPAP significantly improved all scales compared to entry. VAS scores remained lower at 6 months GA compared to entry. Re-adjustment of CPAP pressure was needed in six subjects at 6 months GA.
CONCLUSION: Nasal CPAP is a safe and effective treatment of SDB during pregnancy.

Entities:  

Mesh:

Year:  2004        PMID: 14725826     DOI: 10.1016/j.sleep.2003.07.001

Source DB:  PubMed          Journal:  Sleep Med        ISSN: 1389-9457            Impact factor:   3.492


  21 in total

1.  Sleep apnea and pregnancy. An association worthy of study.

Authors:  Felix Del Campo; Carlos Zamarrón
Journal:  Sleep Breath       Date:  2012-08-09       Impact factor: 2.816

2.  Epworth sleepiness scale scores and adverse pregnancy outcomes.

Authors:  Sophia E Schiza; Izolde Bouloukaki; Charalampos Mermigkis
Journal:  Sleep Breath       Date:  2013-03-13       Impact factor: 2.816

3.  Can gestational hypertension be modified by treating nocturnal airflow limitation?

Authors:  John Reid; Regina Taylor-Gjevre; John Gjevre; Robert Skomro; Mark Fenton; Femi Olatunbosun; John R Gordon; David Cotton
Journal:  J Clin Sleep Med       Date:  2013-04-15       Impact factor: 4.062

Review 4.  Gestational intermittent hypoxia increases susceptibility to neuroinflammation and alters respiratory motor control in neonatal rats.

Authors:  Stephen M Johnson; Karanbir S Randhawa; Jenna J Epstein; Ellen Gustafson; Austin D Hocker; Adrianne G Huxtable; Tracy L Baker; Jyoti J Watters
Journal:  Respir Physiol Neurobiol       Date:  2017-11-22       Impact factor: 1.931

5.  Validation of Watch-PAT-200 against polysomnography during pregnancy.

Authors:  Louise M O'Brien; Alexandra S Bullough; Anita V Shelgikar; Mark C Chames; Roseanne Armitage; Ronald D Chervin
Journal:  J Clin Sleep Med       Date:  2012-06-15       Impact factor: 4.062

Review 6.  The relationship and potential mechanistic pathways between sleep disturbances and maternal hyperglycemia.

Authors:  Bilgay Izci-Balserak; Grace W Pien
Journal:  Curr Diab Rep       Date:  2014-02       Impact factor: 4.810

7.  [Bilateral pallidal infarction in sleep apnea syndrome].

Authors:  P J Egan; F-W Becker; R Bundt
Journal:  Nervenarzt       Date:  2005-12       Impact factor: 1.214

Review 8.  Sleep-disordered breathing in pregnancy: a review of the physiology and potential role for positional therapy.

Authors:  S Morong; B Hermsen; N de Vries
Journal:  Sleep Breath       Date:  2013-04-17       Impact factor: 2.816

Review 9.  Sleep-disordered breathing during pregnancy: future implications for cardiovascular health.

Authors:  Galit Levi Dunietz; Ronald David Chervin; Louise Margaret O'Brien
Journal:  Obstet Gynecol Surv       Date:  2014-03       Impact factor: 2.347

10.  Clinical guidelines for the use of unattended portable monitors in the diagnosis of obstructive sleep apnea in adult patients. Portable Monitoring Task Force of the American Academy of Sleep Medicine.

Authors:  Nancy A Collop; W McDowell Anderson; Brian Boehlecke; David Claman; Rochelle Goldberg; Daniel J Gottlieb; David Hudgel; Michael Sateia; Richard Schwab
Journal:  J Clin Sleep Med       Date:  2007-12-15       Impact factor: 4.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.